{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:30:37Z","timestamp":1790231437515,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T00:00:00Z","timestamp":1729641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-024-11146-z","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T02:02:27Z","timestamp":1729648947000},"page":"2474-2486","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Longitudinal evaluation of pediatric and young adult metabolic dysfunction-associated steatotic liver disease defined by MR elastography"],"prefix":"10.1007","volume":"35","author":[{"given":"Vinicius de Padua V.","family":"Alves","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marialena","family":"Mouzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavra A.","family":"Xanthakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean A.","family":"Tkach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiarong","family":"Ouyang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan R.","family":"Dillman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1431-4054","authenticated-orcid":false,"given":"Andrew T.","family":"Trout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,23]]},"reference":[{"key":"11146_CR1","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1016\/S2468-1253(21)00183-7","volume":"6","author":"M Eslam","year":"2021","unstructured":"Eslam M, Alkhouri N, Vajro P et al (2021) Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement. Lancet Gastroenterol Hepatol 6:864\u2013873. https:\/\/doi.org\/10.1016\/S2468-1253(21)00183-7","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"11146_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhepr.2023.100685","volume":"5","author":"L Draijer","year":"2023","unstructured":"Draijer L, Voorhoeve M, Troelstra M et al (2023) A natural history study of pediatric non-alcoholic fatty liver disease over 10 years. JHEP Rep 5:100685. https:\/\/doi.org\/10.1016\/j.jhepr.2023.100685","journal-title":"JHEP Rep"},{"key":"11146_CR3","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1053\/j.gastro.2020.07.034","volume":"159","author":"SA Xanthakos","year":"2020","unstructured":"Xanthakos SA, Lavine JE, Yates KP et al (2020) Progression of fatty liver disease in children receiving standard of care lifestyle advice. Gastroenterology 159:1731\u20131751.e10. https:\/\/doi.org\/10.1053\/j.gastro.2020.07.034","journal-title":"Gastroenterology"},{"key":"11146_CR4","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jpeds.2018.05.024","volume":"201","author":"M Mouzaki","year":"2018","unstructured":"Mouzaki M, Trout AT, Arce-Clachar AC et al (2018) Assessment of nonalcoholic fatty liver disease progression in children using magnetic resonance imaging. J Pediatr 201:86\u201392. https:\/\/doi.org\/10.1016\/j.jpeds.2018.05.024","journal-title":"J Pediatr"},{"key":"11146_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.cld.2015.10.003","volume":"20","author":"NP Goyal","year":"2016","unstructured":"Goyal NP, Schwimmer JB (2016) The progression and natural history of pediatric nonalcoholic fatty liver disease. Clin Liver Dis 20:325\u2013338. https:\/\/doi.org\/10.1016\/j.cld.2015.10.003","journal-title":"Clin Liver Dis"},{"key":"11146_CR6","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1148\/radiol.2017161398","volume":"285","author":"SD Serai","year":"2017","unstructured":"Serai SD, Obuchowski NA, Venkatesh SK et al (2017) Repeatability of MR elastography of liver: a meta-analysis. Radiology 285:92\u2013100. https:\/\/doi.org\/10.1148\/radiol.2017161398","journal-title":"Radiology"},{"key":"11146_CR7","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1007\/s00261-017-1289-y","volume":"43","author":"M Joshi","year":"2018","unstructured":"Joshi M, Dillman JR, Singh K et al (2018) Quantitative MRI of fatty liver disease in a large pediatric cohort: correlation between liver fat fraction, stiffness, volume, and patient-specific factors. Abdom Radiol (NY) 43:1168\u20131179. https:\/\/doi.org\/10.1007\/s00261-017-1289-y","journal-title":"Abdom Radiol (NY)"},{"key":"11146_CR8","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1148\/radiol.2017170550","volume":"286","author":"T Yokoo","year":"2018","unstructured":"Yokoo T, Serai SD, Pirasteh A et al (2018) Linearity, bias, and precision of hepatic proton density fat fraction measurements by using MR imaging: a meta-analysis. Radiology 286:486\u2013498. https:\/\/doi.org\/10.1148\/radiol.2017170550","journal-title":"Radiology"},{"key":"11146_CR9","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1016\/j.cgh.2019.10.041","volume":"18","author":"JE Eaton","year":"2020","unstructured":"Eaton JE, Sen A, Hoodeshenas S et al (2020) Changes in liver stiffness, measured by magnetic resonance elastography, associated with hepatic decompensation in patients with primary sclerosing cholangitis. Clin Gastroenterol Hepatol 18:1576\u20131583.e1. https:\/\/doi.org\/10.1016\/j.cgh.2019.10.041","journal-title":"Clin Gastroenterol Hepatol"},{"key":"11146_CR10","doi-asserted-by":"publisher","unstructured":"Gidener T, Dierkhising R, Mara KC et al (2022) Change in serial liver stiffness measurement by magnetic resonance elastography and outcomes in non\u2010alcoholic fatty liver disease. Hepatology. https:\/\/doi.org\/10.1002\/hep.32594","DOI":"10.1002\/hep.32594"},{"key":"11146_CR11","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1136\/gutjnl-2021-324264","volume":"71","author":"N Tamaki","year":"2022","unstructured":"Tamaki N, Munaganuru N, Jung J et al (2022) Clinical utility of 30% relative decline in MRI-PDFF in predicting fibrosis regression in non-alcoholic fatty liver disease. Gut 71:983\u2013990. https:\/\/doi.org\/10.1136\/gutjnl-2021-324264","journal-title":"Gut"},{"key":"11146_CR12","doi-asserted-by":"publisher","first-page":"169","DOI":"10.2214\/AJR.21.27164","volume":"219","author":"AT Huber","year":"2022","unstructured":"Huber AT, Obmann V (2022) Beyond the AJR: prognostic value of a single baseline liver stiffness measurement by MR elastography in patients with chronic liver disease. AJR Am J Roentgenol 219:169. https:\/\/doi.org\/10.2214\/AJR.21.27164","journal-title":"AJR Am J Roentgenol"},{"key":"11146_CR13","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/apt.16745","volume":"55","author":"M Higuchi","year":"2022","unstructured":"Higuchi M, Tamaki N, Kurosaki M et al (2022) Longitudinal association of magnetic resonance elastography-associated liver stiffness with complications and mortality. Aliment Pharmacol Ther 55:292\u2013301. https:\/\/doi.org\/10.1111\/apt.16745","journal-title":"Aliment Pharmacol Ther"},{"key":"11146_CR14","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.1001\/jama.2011.520","volume":"305","author":"JE Lavine","year":"2011","unstructured":"Lavine JE, Schwimmer JB, Van Natta ML et al (2011) Effect of vitamin E or metformin for treatment of nonalcoholic fatty liver disease in children and adolescents the tonic randomized controlled trial. JAMA 305:1659\u20131668. https:\/\/doi.org\/10.1001\/jama.2011.520","journal-title":"JAMA"},{"key":"11146_CR15","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1053\/j.gastro.2016.08.027","volume":"151","author":"JB Schwimmer","year":"2016","unstructured":"Schwimmer JB, Lavine JE, Wilson LA et al (2016) In children with nonalcoholic fatty liver disease, cysteamine bitartrate delayed release improves liver enzymes but does not reduce disease activity scores. Gastroenterology 151:1141\u20131154.e9. https:\/\/doi.org\/10.1053\/j.gastro.2016.08.027","journal-title":"Gastroenterology"},{"key":"11146_CR16","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","volume":"78","author":"ME Rinella","year":"2023","unstructured":"Rinella ME, Lazarus JV, Ratziu V et al (2023) A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Hepatology 78:1966\u20131986. https:\/\/doi.org\/10.1097\/HEP.0000000000000520","journal-title":"Hepatology"},{"key":"11146_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/chi.2022.0136","volume":"X","author":"VPV Alves","year":"2022","unstructured":"Alves VPV, Trout AT, Dewit M et al (2022) Clinical performance of transient elastography with comparison to quantitative magnetic resonance imaging, ultrasound, and biopsy in children and adolescents with known or suspected fatty liver disease. Child Obes X:1\u20139. https:\/\/doi.org\/10.1089\/chi.2022.0136","journal-title":"Child Obes"},{"key":"11146_CR18","unstructured":"BMI (2024) Calculator Child and Teen. Healthy Weight. CDC. https:\/\/www.cdc.gov\/healthyweight\/bmi\/calculator.html. Accessed 8 Sep 2021"},{"key":"11146_CR19","unstructured":"QIBA MR Biomarker Committee (2022) MR elastography of the liver, quantitative imaging biomarkers alliance. Available via https:\/\/qibawiki.rsna.org\/index.php\/Profiles"},{"key":"11146_CR20","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1053\/j.gastro.2022.06.073","volume":"163","author":"V Ajmera","year":"2022","unstructured":"Ajmera V, Kim BK, Yang K et al (2022) Liver stiffness on magnetic resonance elastography and the MEFIB index and liver-related outcomes in nonalcoholic fatty liver disease: a systematic review and meta-analysis of individual participants. Gastroenterology 163:1079\u20131089.e5. https:\/\/doi.org\/10.1053\/j.gastro.2022.06.073","journal-title":"Gastroenterology"},{"key":"11146_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1001\/jamanetworkopen.2021.23923","volume":"4","author":"ZM Younossi","year":"2021","unstructured":"Younossi ZM, Felix S, Jeffers T et al (2021) Performance of the enhanced liver fibrosis test to estimate advanced fibrosis among patients with nonalcoholic fatty liver disease. JAMA Netw Open 4:1\u201311. https:\/\/doi.org\/10.1001\/jamanetworkopen.2021.23923","journal-title":"JAMA Netw Open"},{"key":"11146_CR22","doi-asserted-by":"publisher","first-page":"445","DOI":"10.14218\/JCTH.2020.00033","volume":"8","author":"H Wei","year":"2020","unstructured":"Wei H, Song B (2020) Elastography for longitudinal assessment of liver fibrosis after antiviral therapy: a review. J Clin Transl Hepatol 8:445\u2013453. https:\/\/doi.org\/10.14218\/JCTH.2020.00033","journal-title":"J Clin Transl Hepatol"},{"key":"11146_CR23","doi-asserted-by":"publisher","first-page":"1915","DOI":"10.1016\/j.cgh.2020.09.044","volume":"19","author":"T Gidener","year":"2021","unstructured":"Gidener T, Ahmed OT, Larson JJ et al (2021) Liver stiffness by magnetic resonance elastography predicts future cirrhosis, decompensation, and death in NAFLD. Clin Gastroenterol Hepatol 19:1915\u20131924.e6. https:\/\/doi.org\/10.1016\/j.cgh.2020.09.044","journal-title":"Clin Gastroenterol Hepatol"},{"key":"11146_CR24","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1002\/hep.30974","volume":"71","author":"VH Ajmera","year":"2020","unstructured":"Ajmera VH, Liu A, Singh S et al (2020) Clinical utility of an increase in magnetic resonance elastography in predicting fibrosis progression in nonalcoholic fatty liver disease. Hepatology 71:849\u2013860. https:\/\/doi.org\/10.1002\/hep.30974","journal-title":"Hepatology"},{"key":"11146_CR25","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/hep.32151","volume":"75","author":"T Gidener","year":"2022","unstructured":"Gidener T, Yin M, Dierkhising RA et al (2022) Magnetic resonance elastography for prediction of long-term progression and outcome in chronic liver disease: a retrospective study. Hepatology 75:379\u2013390. https:\/\/doi.org\/10.1002\/hep.32151","journal-title":"Hepatology"},{"key":"11146_CR26","doi-asserted-by":"publisher","unstructured":"Allen AM, Younossi ZM, Tsochatzis EA et al (2023) Measuring NAFLD models of care. Nat Rev Gastroenterol Hepatol. https:\/\/doi.org\/10.1038\/s41575-023-00798-9","DOI":"10.1038\/s41575-023-00798-9"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-024-11146-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-024-11146-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-024-11146-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T11:05:23Z","timestamp":1745492723000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-024-11146-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,23]]},"references-count":26,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,5]]}},"alternative-id":["11146"],"URL":"https:\/\/doi.org\/10.1007\/s00330-024-11146-z","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,23]]},"assertion":[{"value":"8 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Andrew T. Trout.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"J.R.D. has received unrelated research support from Philips Healthcare, GE Healthcare, and Perspectum Inc. A.T.T. has received unrelated research funding from Perspectum Inc. A.T.T. and J.R.D. has received related investigator-initiated research funding from Canon Medical System and Siemens Healthineers. S.A.X. and M.M. have received unrelated research funding from Target RWE. The remaining authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Bin Zhang and Jiarong Ouyang kindly provided statistical advice for this manuscript.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was waived by the Institutional Review Board.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"Institutional Review Board approval was obtained.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Data from thirty-seven patients included in this study were previously reported in a retrospective study that assessed NAFLD progression in children using paired MR elastography. Mouzaki et al (2018) [], .","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}